HealthDay News: Cancer
Annual COPD Costs To Hit $49 Billion by 2020: CDC
WEDNESDAY, July 30, 2014 (HealthDay News) -- Medical costs for
chronic obstructive pulmonary disease (COPD) in the United States
are more than $32 billion each year, according to new research from
the U.S. Centers for Disease Control and Prevention.
FDA Expands Use of Imbruvica for Form of Leukemia
MONDAY, July 28, 2014 (HealthDay News) -- Approved use for Imbruvica (ibrutinib) has been expanded to include people with chronic lymphocytic leukemia (CLL) who have a deletion in chromosome 17, the U.S. Food and Drug Administration said Monday in a news release.
Too Few Teens Receive HPV Shot, CDC Says
THURSDAY, July 24, 2014 (HealthDay News) -- An "unacceptably low" number of girls and boys are getting the human papillomavirus (HPV) vaccine, which protects against cervical, anal and other cancers, U.S. health officials said Thursday.
Zydelig Approved for Three Types of Blood Cancer
WEDNESDAY, July 23, 2014 (HealthDay News) -- Zydelig (idelalisib) has been approved by the U.S. Food and Drug Administration to treat relapsed forms of blood cancer, including chronic lymphocytic leukemia (CLL), follicular B-cell non-Hodgkin lymphoma (FL) and small lymphocytic lymphoma (SLL), the FDA said Wednesday in a news release.